drugset / Trial / NCT00840320
Repeat Dose Safety Study for Compound to Treat Anemia
RandomizedParallel-groupSingle-blindBasic science
Summary
The purpose of this study is to characterize the safety and tolerability of repeat doses of compound 1278863A in healthy subjects.
Timeline
- Start
- 2009-03-13
- Primary completion
- 2009-09-02
- Completion
- 2009-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 1278863 | Unknown | 15 mg | Oral |
| Subject | 1278863 | Unknown | 25 mg | Oral |
| Subject | 1278863 | Unknown | 50 mg | Oral |
| Subject | 1278863 | Unknown | 150 mg | Oral |